Resiniferatoxin

N/A

Report date: 2026/04/27 20:02:09
NME

Base Information

Drug NameResiniferatoxin
Drug Alias NameLopain树酯毒素仙人掌毒素树胶脂毒素MTX-071 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVanilloid receptor agonists
TargetsTransient receptor potential cation channel subfamily V member 1
Therapy Area/IndicationsChronic Knee PainPain, IntractableCancer Pain +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBulgariaCanada +[17] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesNational Institute of Health, Islamabad
China Registration ClassN/A

Develop Information

Active CompaniesNational Institutes Of Health Clinical Center (Cc)Grünenthal GmbHSorrento Therapeutics Inc +[6] 
Inactive CompaniesIcos Corporation
Active IndicationsChronic Knee PainPain, IntractableOsteoarthritis, Knee +[5] 
Inactive IndicationsCancer PainPainCystitis, Interstitial

Other Information

ATC CodeN/A
Related LinksWikipedia